These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12849428)

  • 1. New systems for delivery of drugs to the brain in neurological disease.
    Cornford EM; Cornford ME
    Lancet Neurol; 2002 Sep; 1(5):306-15. PubMed ID: 12849428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.
    Barbu E; Molnàr E; Tsibouklis J; Górecki DC
    Expert Opin Drug Deliv; 2009 Jun; 6(6):553-65. PubMed ID: 19435406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
    Patching SG
    Mol Neurobiol; 2017 Mar; 54(2):1046-1077. PubMed ID: 26801191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
    Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
    Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-Appended BBB-Targeted Nanocarriers (LABTNs).
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2015; 32(2):149-80. PubMed ID: 25955883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector-mediated drug delivery to the brain.
    Temsamani J; Rousselle C; Rees AR; Scherrmann JM
    Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system.
    Burdo JR; Antonetti DA; Wolpert EB; Connor JR
    Neuroscience; 2003; 121(4):883-90. PubMed ID: 14580938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technologies for drug delivery across the blood brain barrier.
    Kabanov AV; Batrakova EV
    Curr Pharm Des; 2004; 10(12):1355-63. PubMed ID: 15134486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier transport of drugs for the treatment of brain diseases.
    Gabathuler R
    CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):195-204. PubMed ID: 19601817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders.
    Yadav K; Vijayalakshmi R; Kumar Sahu K; Sure P; Chahal K; Yadav R; Sucheta ; Dubey A; Jha M; Pradhan M
    Eur J Pharm Biopharm; 2024 Jun; 199():114298. PubMed ID: 38642716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular devices to improve the treatment of brain diseases.
    Paolino D; Cosco D; Molinaro R; Celia C; Fresta M
    Drug Discov Today; 2011 Apr; 16(7-8):311-24. PubMed ID: 21335100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain drug targeting and gene technologies.
    Pardridge WM
    Jpn J Pharmacol; 2001 Oct; 87(2):97-103. PubMed ID: 11700018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand conjugation: An emerging platform for enhanced brain drug delivery.
    Nabi B; Rehman S; Khan S; Baboota S; Ali J
    Brain Res Bull; 2018 Sep; 142():384-393. PubMed ID: 30086350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.